Navigation Links
Sysmex Corporation Announces Organizational Changes
Date:3/5/2009

The Americas, Europe and Asia to Realize New Executive Leadership

KOBE, Japan, March 5 /PRNewswire/ -- Sysmex Corporation (6869: Tokyo Stock Exchange), a leading medical diagnostics instrument manufacturer and laboratory information systems developer, today announced executive leadership changes at Sysmex Corporate and its subsidiaries in the Americas, Europe and Asia.

Effective April 1, 2009, Kazuya Obe will return to Sysmex Corporate after a six-year tenure in the United States and serve in an International Business leadership position. He will report directly to the President and CEO of Sysmex Corporation, Hisashi Ietsugu. Currently, Obe is Chairman and CEO of Sysmex America, Inc. John Kershaw, who is presently serving as President and COO of Sysmex America, will be promoted to President and CEO of Sysmex America, Inc. and head of the Americas Region, which includes North America, Central America and Latin America. Kershaw will report directly to Kazuya Obe. Sysmex Corporate Director of International Marketing, Tak Ono, will transfer to Sysmex America to serve as its Vice President of Business Planning.

Sysmex Corporate European subsidiary, Sysmex Europe GMBH will operate under the leadership of Masahide Azuma, who is being inaugurated as Chairman of the Board of Sysmex Europe GMBH. He also will assume a new role as Sysmex Corporation's representative and will report directly to Kazuya Obe. Currently, Azuma is Chairman and CEO of Sysmex Europe GMBH. Dr. Michael Schaefer, the current President and COO of Sysmex Europe GMBH, will be promoted to President and CEO of Sysmex Europe GMBH and the operational head of the European Region. Schaefer will report to Masahide Azuma.

Other direct reports to Kazuya Obe will include Frank Buescher, President and CEO, Sysmex Asia Pacific PTE LTD and head of the Asian Pacific Region; and Yutaka Higuchi, Chairman of Sysmex Shanghai and head of Chi
'/>"/>

SOURCE Sysmex America
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Sysmex America Introduces On Demand Middleware Training Tool
2. Sysmex Customer Satisfaction Ranks Highest in Independent Market Research
3. Sysmex America to Release e-Verify(TM), Powered By SNCS(TM)
4. Sysmex Announces Brand Change
5. Sysmex America to Enable Prolonged Hematology Instrument Uptime for Hagerstown Medical Laboratory With 1,000th SNCS Activation
6. Sysmex America Receives FDA Clearance for XE-5000(TM) Hematology Analyzer
7. Sysmex America Awarded Hematology Contract by Amerinet
8. Digirad Corporation Sells Arizona, Nevada Service Hubs
9. Pharmos Corporation Announces Modification to Dextofisopam Trial Size, Objectives Can Still Be Achieved
10. CVS Caremark Corporation Announces Quarterly Dividend
11. AMERIGROUP Corporation to Present at the Barclays Capital Global Healthcare Conference on March 10
Post Your Comments:
*Name:
*Comment:
*Email:
Other Medicine News:Health News:Average Annual Medical Premium Costs Increased 6%, Says 2008 Benefit Plan Report from C&B Consulting 2Health News:JUVA Skin & Laser Center Introduces Affirm CO2 to New York City Laser Resurfacing Clients 2Health News:Chiltern's Resourcing Solutions Division Appoints New Managers to Spain and the United Kingdom 2Health News:Stiefel Laboratories Completes Acquisition of Barrier Therapeutics 2Health News:Stiefel Laboratories Completes Acquisition of Barrier Therapeutics 3Health News:The Ensign Group, Inc. Reports Second Quarter 2008 Earnings of $.32 per Diluted Share and Raises 2008 Guidance 2Health News:The Ensign Group, Inc. Reports Second Quarter 2008 Earnings of $.32 per Diluted Share and Raises 2008 Guidance 3Health News:The Ensign Group, Inc. Reports Second Quarter 2008 Earnings of $.32 per Diluted Share and Raises 2008 Guidance 4Health News:The Ensign Group, Inc. Reports Second Quarter 2008 Earnings of $.32 per Diluted Share and Raises 2008 Guidance 5Health News:The Ensign Group, Inc. Reports Second Quarter 2008 Earnings of $.32 per Diluted Share and Raises 2008 Guidance 6Health News:The Ensign Group, Inc. Reports Second Quarter 2008 Earnings of $.32 per Diluted Share and Raises 2008 Guidance 7Health News:The Ensign Group, Inc. Reports Second Quarter 2008 Earnings of $.32 per Diluted Share and Raises 2008 Guidance 8Health News:The Ensign Group, Inc. Reports Second Quarter 2008 Earnings of $.32 per Diluted Share and Raises 2008 Guidance 9Health News:The Ensign Group, Inc. Reports Second Quarter 2008 Earnings of $.32 per Diluted Share and Raises 2008 Guidance 10Health News:The Ensign Group, Inc. Reports Second Quarter 2008 Earnings of $.32 per Diluted Share and Raises 2008 Guidance 11Health News:NHP Reports Second Quarter 2008 Earnings 2Health News:NHP Reports Second Quarter 2008 Earnings 3Health News:NHP Reports Second Quarter 2008 Earnings 4Health News:NHP Reports Second Quarter 2008 Earnings 5Health News:NHP Reports Second Quarter 2008 Earnings 6Health News:NHP Reports Second Quarter 2008 Earnings 7Health News:NHP Reports Second Quarter 2008 Earnings 8Health News:NHP Reports Second Quarter 2008 Earnings 9Health News:NHP Reports Second Quarter 2008 Earnings 10Health News:NHP Reports Second Quarter 2008 Earnings 11Health News:NHP Reports Second Quarter 2008 Earnings 12Health News:NHP Reports Second Quarter 2008 Earnings 13Health News:NHP Reports Second Quarter 2008 Earnings 14
Breaking Medicine Technology:AdvanDx Receives FDA 510(k) Clearance for 90 Minutes PNA FISH(R) Protocol for Identifying Staphylococcal Bloodstream Pathogens 2AdvanDx Receives FDA 510(k) Clearance for 90 Minutes PNA FISH(R) Protocol for Identifying Staphylococcal Bloodstream Pathogens 3China-Biotics, Inc. to Hold 2009 Annual Meeting of Stockholders on March 5, 2010 2China-Biotics, Inc. to Hold 2009 Annual Meeting of Stockholders on March 5, 2010 3New National Pharmaceutical Council Report Provides Guidance on Evaluating Comparative Effectiveness Studies 2Half of the fish consumed globally is now raised on farms study finds 9813 1Half of the fish consumed globally is now raised on farms study finds 9813 2Half of the fish consumed globally is now raised on farms study finds 9813 3Let Orthopedic Surgery Wait Until Morning When Possible 56337 1REGURIN 28R 29 XL 28trospium chloride 29 Once Daily Tablets Now Available in the UK for the Treatment of Overactive Bladder 56335 1REGURIN 28R 29 XL 28trospium chloride 29 Once Daily Tablets Now Available in the UK for the Treatment of Overactive Bladder 56335 2REGURIN 28R 29 XL 28trospium chloride 29 Once Daily Tablets Now Available in the UK for the Treatment of Overactive Bladder 56335 3REGURIN 28R 29 XL 28trospium chloride 29 Once Daily Tablets Now Available in the UK for the Treatment of Overactive Bladder 56335 4REGURIN 28R 29 XL 28trospium chloride 29 Once Daily Tablets Now Available in the UK for the Treatment of Overactive Bladder 56335 5